Tobacco-use cessation programs and policies at the University of Manitoba's faculty of dentistry
Related Experiment Video
Updated: Oct 8, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
1Department of Dental Diagnostic and Surgical Sciences, Faculty of Dentistry, University of Manitoba, 780 Bannatyne Ave., Winnipeg, MB R3E 0W2. shirley_gelskey@umanitoba.ca
Abstract:
The deleterious effects of tobacco use on general health and oral health are well documented. While one-third of Manitobans are current smokers, up to 79% report they want to quit. Counselling by health care professionals can help achieve quit rates of 15-20%. Yet many health professionals do not provide tobacco-use cessation counselling because they feel they are not trained to do so. In 1998, the faculty of dentistry of the University of Manitoba implemented a number of tobacco-use cessation interventions in its undergraduate curricula and general teaching clinic. The faculty has also successfully obtained the inclusion of a dental fee code for tobacco-use cessation services in the provincial fee guide and has received approval to allow dentists who have completed an approved course in tobacco-use cessation training to prescribe bupropion HCl (Zyban), in consultation with a patient's physician, to aid smoking cessation.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
PPE Use in Healthcare Settings II: Doffing